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In rat erythrocytes, the regulation of Na+/Mg2+ antiport by protein kinases (PKs), protein phosphatases (PPs), intracellular Mg2+, ATP and
Cl was investigated. In untreated erythrocytes, Na+/Mg2+ antiport was slightly inhibited by the PK inhibitor staurosporine, slightly
stimulated by the PP inhibitor calyculin A and strongly stimulated by vanadate. PMA stimulated Na+/Mg2+ antiport. This effect was
completely inhibited by staurosporine and partially inhibited by the PKC inhibitors Ro-31-8425 and BIM I. Participation of other PKs such as
PKA, the MAPK cascade, PTK, CK I, CK II, CAM II-K, PI 3-K, and MLCK was excluded by use of inhibitors. Na+/Mg2+ antiport in rat
erythrocytes can thus be stimulated by PKCa.
In non-Mg2+-loaded erythrocytes, ATP depletion reduced Mg2+ efflux and PMA stimulation in NaCl medium. A drastic activation of Na+/
Mg2+ antiport was induced by Mg2+ loading which was not further stimulated by PMA. Staurosporine, Ro-31-8425, BIM I and calyculin A
did not inhibit Na+/Mg2+ antiport of Mg2+-loaded cells. Obviously, at high [Mg2+]i Na
+/Mg2+ antiport is maximally stimulated. PKCa or PPs
are not involved in stimulation by intracellular Mg2+. ATP depletion of Mg2+-loaded erythrocytes reduced Mg2+ efflux and the affinity of
Mg2+ binding sites of the Na+/Mg2+ antiporter to Mg2+. In non-Mg2+-loaded erythrocytes Na+/Mg2+ antiport essentially depends on Cl.
Mg2+-loaded erythrocytes were less sensitive to the activation of Na+/Mg2+ antiport by [Cl]i.
D 2004 Elsevier B.V. All rights reserved.Keywords: Na+/Mg2+ antiport; Rat erythrocyte; PKCa; [Mg2+]i; ATP; [Cl
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1. Introduction Na+/Mg antiport is drastically activated by loading eryth-Na+/Mg2+ antiport can be regulated by intracellular
Mg2+, ATP and Cl. Evidence is as follows.0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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Abbreviations: BIM I, bisindolylmaleimide I; CAM II-K, calmodulin-
dependent kinase II; CK I, casein kinase I; CK II, casein kinase II; DAG,
diacylglycerol; 2,3 BPG, 2,3 bisphosphoglycerate; GAPDH, glycerol-
aldehyde-phosphate dehydrogenase; MAPK, mitogen-activated protein
kinase; MLCK, myosine light chain kinase; PI 3-K, phosphatidyl-
inositol-3 kinase; PK, protein kinase; PKA, cAMP-dependent protein
kinase; PKC, protein kinase C; PKG, cGMP-dependent protein kinase;
PLC, phospholipase C; PMA, phorbol-12-myristate-13-acetate; PP, protein
phosphatase; PP 1, protein phosphatase 1; PP 2A, protein phosphatase 2A;
PTP 1B, protein tyrosine phosphatase 1B; PTK, protein tyrosine kinase; Sp-
5,6-DCl-cBIMPS, 5,6 dichloro-1-h-D-ribofuranosylbenzimidazole 3V,5V
cyclic monophosphorothiorate, sp-isomer, sodium salt; TCA, trichloro-
acetic acid; TRPM, transient receptor potential melastatin-like channel
subfamily; [X]i, intracellular concentration of a cation or an anion
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1 This study constitutes part of her thesis.rocytes with Mg2+ [1,2]. In analogy to Na+/Mg2+ antiport,
Na+/H+ antiport is activated by intracellular H+ [3–5], and
Na+/Ca2+ antiport by intracellular Ca2+ [6–8].
Na+/Mg2+ antiport is dependent on ATP. Inhibition of
energy metabolism reduced the activity of Na+/Mg2+ anti-
port in chicken erythrocytes [9]. In rat [10] and human
[11,12] erythrocytes, ATP depletion reduced Na+/Mg2+
antiport and reversed Na+/Mg2+ antiport in rat erythrocytes
[13] by decreasing the affinity of the Na+/Mg2+ antiporter
for intracellular Mg2+. This was shown by an increase in log
K in the Hill plot [13]. Like Na+/Mg2+ antiport, other
secondary active transport systems, e.g. Na+/H+ antiport,
Na+/Ca2+ antiport, Na+,K+,Cl symport and K+,Cl sym-
port, also depend on ATP [14–17]. The mechanism of
action of ATP in these transport systems has been contro-
versially discussed [14–16]. The Na+,K+,Cl symporter is
active when two threonines are phosphorylated [17]. Re-
cently, it was found that the Na+/Ca2+ antiporter is phos-
phorylated by PKA and PKC in the form of a
macromolecular complex [16].
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mediated by phosphorylation of the Na+/Mg2+ antiporter
similarly as in Na+/Ca2+ antiport [16] and Na+,K+,Cl
symport [17]. Amiloride-sensitive phosphorylation of an
erythrocyte membrane protein has already been found [18].
In line with these results, it was possible to stimulate Na+/
Mg2+ antiport in various cell types by effectors that
stimulate phosphorylation, for example in rat erythrocytes
by a phorbol ester [13], and in thymocytes [19], ascites
cells [20] and liver cells [21] by a cell permeant cAMP
analog, which activates PKA. In rat liver cells, Mg2+ efflux
by Na+/Mg2+ antiport evoked following stimulation of h-
adrenergic receptors [21,22]. The same was observed when
hepatocytes were stimulated by forskolin [21]. In Mg2+-
deprived cultured mouse distal convoluted tubule cells
(MDCT), isoproterenol [23], Br-cAMP [24], PGE2 [25]
and adenosine [26] stimulated Mg2+ influx via Na+/Mg2+
antiport. Also, in perfused rat heart, Na+/Mg2+ antiport was
stimulated by h-adrenergics [27,28]. These results indicate
a role of PKA in the activation of Na+/Mg2+ antiport of
several tissues.
Stimulation of a1-adrenergic receptors induced Mg
2+
efflux from rat hepatocytes [29], a Na+-dependent one via
Na+/Mg2+ antiport and a Ca2+-dependent one [30]. This was
taken as evidence for a PLC signaling pathway resulting in
activation of PKC by the increased production of DAG.
Thus, in addition to PKA, Na+/Mg2+ transport can also be
affected by PKC.
Finally, it should be noted that in Mg2+-loaded renal
epithelial cells, Na+/Mg2+ antiport was activated by nitric
oxide and cGMP [31]. This points to a possible third way of
regulating Na+/Mg2+ antiport via PKG.
We previously found stimulation of Na+/Mg2+ antiport
by intracellular Cl in non-Mg2+-loaded rat erythrocytes. In
analogy, Na+/H+ antiport and Na+,K+,Cl symport were
stimulated by intracellular Cl (for literature, see Ref.
[32]). It has been proposed that the major effect of [Cl]i
on Na+,K+,Cl symport is exerted via a volume-sensitive
protein kinase (PK) [33].
Similar to other transport processes, these findings show
that there is a regulation of Na+/Mg2+ antiport by various
PKs and by the intracellular concentrations of Mg2+, ATP
and Cl. The different activation mechanisms may be
interrelated as shown for the interaction of intracellular
Mg2+ and cAMP in the activation of Na+/Mg2+ antiport
from thymocytes [19].
We therefore investigated the interplay of intracellular
Mg2+, ATP and Cl with various PKs, PPs in the regulation
of Na+/Mg2+ antiport of rat erythrocytes. In order to exclude
a possible ineffectivity in rat erythrocytes, several inhibitors
were used at various concentrations for each PK or PP. As
shown in previous studies by us, rat erythrocytes were
suitable for studying Mg2+ efflux without Mg2+ loading
[1]. It was therefore possible to directly compare Mg2+
efflux of non-Mg2+-loaded and Mg2+-loaded cells and the
effect of Mg2+ loading.2. Materials and methods
2.1. Materials
Nembutal, sodium solution was obtained from Abott
Labs., N. Chicago, IL, USA. A 23187 from Molecular
Probes, Eugene, Or., USA, isoproterenol, and sodium
orthovanadate from Sigma, Taufkirchen, Germany. The
inhibitors or stimulators of the various PKs and PPs were
from Calbiochem Novabiochem GmbH, Bad Soden, Ger-
many. All other chemicals were purchased from Merck
Eurolab GmbH, Darmstadt, Germany at the highest grade
of purity available. Filtered, deionized and virtually Mg2+-
free water with a resistance of 15–18 MV/cm was used for
solutions.
2.2. Red cell preparation and incubation
By catheterizing the abdominal vein with a heparinized
syringe, blood (6–8 ml) was obtained from one anesthetized
male Sprague Dawley rat (50 mg/kg NembutalR i.p.),
weighing 350–450 g. The blood was transferred to several
heparinized tubes and diluted 1:5 with a solution containing
(in mmol l 1) 150 NaCl, 5 glucose, 10 HEPES–Tris, pH
7.4 (NaCl medium). The cell suspension was centrifuged at
1000 g for 10 min. The supernatant plasma and buffy coat
containing the white cells were aspirated and discarded. The
red cells were washed twice in 10-ml NaCl medium. Finally,
the red cells were suspended as a 10% suspension (v/v) in
NaCl, NaSCN, KCl, or KSCN medium containing (in mmol
l 1) 150 of each salt, 5 glucose, 10 HEPES–Tris, pH 7.4.
Paired experiments were conducted throughout in the dif-
ferent media with various inhibitors or stimulators.
To avoid hemolysis, the cells were handled with great
caution. The experimental temperature was therefore set to
24 jC, and low-speed centrifugation was used.
2.3. ATP depletion
ATP depletion of rat erythrocytes was performed by
substituting 5 mmol l 1 D-glucose in the media during
washing and incubation by 5 mmol l 1 deoxyglucose.
Furthermore, 1 mmol l 1 iodoacetate was added to the
media.
2.4. Mg2+ loading
The cells were loaded with Mg2+ by incubating a 10% (v/
v) cell suspension for 30 min at 37 jC in Mg2+ loading
medium containing (in mmol l 1) 140 KCl, 50 sucrose, 5 D-
glucose and 10 HEPES–Tris, pH 7.4, 12 MgCl2 and 6 Amol
l 1 A 23187 (dissolved in dimethyl sulfoxide). The slightly
hypertonic loading medium protected the cells against
hemolysis. After loading, the ionophore was removed by
incubating the cells four times in ionophore-free Mg2+
loading medium plus 1% bovine serum albumin for 10
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times in the desired cooled isotonic incubation media.
2.5. Mg2+ efflux
Mg2+ transport was determined by measuring the
increase of Mg2+ concentration in the incubation medium.
At the beginning and end of an experiment, 1-ml aliquots
of the cell suspensions were centrifuged at 1000 g for
10 min. Unless otherwise indicated, the incubation at 24
jC lasted 2 h in non-Mg2+-loaded erythrocytes and 10 to
30 min in Mg2+-loaded erythrocytes. To determine Mg2+,
the supernatant was diluted with 5% (w/v) TCA, contain-
ing 0.1% (w/v) La2O3 and 0.16% (v/v) HCl. Mg
2+ was
measured in triplicate by means of atomic absorption
spectrometry (Perkin Elmer, 2380). Mg2+ efflux was
calculated from the increase in extracellular Mg2+ con-
centration during the time interval, and was related to the
original cell volume measured with hematocrit. Hemato-
crit and hemolysis were measured in each sample. Mg2+
efflux was corrected for hemolysis. For this purpose, TCA
was added to the sedimented erythrocytes and the Mg2+
content of the TCA extract was determined. Where
hemolysis was greater than 2%, the red cells were not
taken for the experiment.
2.6. Statistical analysis
Data were expressed as mean valuesF S.E., and statis-
tical differences were determined using Student’s paired and
two-tailed t test. A value of P < 0.05 was considered
significant.Table 1
Effect of the PK inhibitors staurosporine and BIM I and of the PP inhibitors
okadaic acid and calyculin A on Mg2+ efflux of non-PMA-treated rat
erythrocytes in NaCl medium or NaSCN medium
Group NaCl medium
(Amol l cells1
2 h1)
P NaSCN medium
(Amol l cells1
2 h1)
P
Control 251.3F7.2 83.7F5.2
Staurosporine,
1.0 Amol l1
214.6F2.8 <0.0001 67.3F1.1 0.0006
BIM I,
1.0 Amol l1
259.1F4.7 n.s. 95.2F4.7 0.0008
Okadaic acid,
0.5 Amol l1
259.9F7.7 0.037 91.4F4.8 0.0096
Calyculin A,
0.5 Amol l1
272.7F19.1 0.011 98.9F6.2 0.0002
MeansFS.E. of five paired experiments.3. Results and discussion
3.1. Mg2+ efflux from untreated erythrocytes
Initially, the effect of PKA, PKC, other PKs and PPs on
Mg2+ efflux was investigated in non-Mg2+-loaded erythro-
cytes. PKA is present in human [34,35] and rabbit eryth-
rocytes [36,37]. To test whether PKA is involved in the
regulation of Na+/Mg2+ antiport, Sp-5,6-DCl-cBIMPS
(0.5–10 Amol l 1), acting as a phosphodiesterase stable
activator, and H 89 (100–1000 nmol l 1), acting as an
inhibitor, were tried. Both drugs had no effect on Mg2+
efflux. Furthermore, the ACase stimulators isoproterenol
(10–100 Amol l 1) and forskolin (100–250 Amol l 1),
which by increased generation of cAMP could stimulate
PKA, also had no significant effect on Mg2+ efflux (data not
shown). An explanation for the failing effect of isoprotere-
nol and forskolin is that, in contrast to human erythrocytes
[34,35], rat erythrocytes do not contain h-adrenergic recep-
tors, which are lost during maturation [38]. From these
results we can exclude a role of PKA in Na+/Mg2+ antiport
of rat erythrocytes.Besides PKA, PKCa and phorbol-ester-insensitive PKC
isoforms are present in human erythrocytes [39–41]. Un-
fortunately, in rat erythrocytes the PKC isoforms have not
been characterized. To determine whether Mg2+ efflux from
non-PMA-treated rat erythrocytes is regulated by PKC, we
tested the unspecific PK inhibitor staurosporine and BIM I,
a more specific inhibitor of the nPKC and cPKC group. As
can be seen from Table 1, staurosporine (1 Amol l 1)
inhibited Mg2+ efflux in NaCl medium by about 15% and
by 20% in NaSCN medium. BIM I (1 Amol l 1) had no
significant effect in NaCl but slightly stimulated Mg2+
efflux by 14% in NaSCN. The reason for the stimulation
of Mg2+ efflux in NaSCN medium by BIM I is not clear.
The PKCa inhibitor resveratrol (1–25 Amol l 1) and Go¨
6976 (250–1000 nmol l 1) had no effect on Mg2+ efflux
(data not shown). These results indicate that PKCa is not
involved in Mg2+ efflux in non-PMA-treated rat erythro-
cytes. Therefore, in untreated erythrocytes, Mg2+ efflux
should be modulated by PKs other than PKA and PKCa.
To our knowledge, there exists no report of any presence
of PKG in rat erythrocytes, which could also be involved in
the regulation of Na+/Mg2+ antiport. A role of PKG was
excluded by using PK inhibitors, which were also reported
as inhibiting PKG. These inhibitors were emodin, genistein,
H89, lavendustin A, and PP2. All these substances were
without effect on Mg2+ efflux (data not shown).
In erythrocytes, the presence of various PTKs such as CK
I [42] and CK II [43], PTKp72syk [44] and PTKp56/53lyn [45],
PI 3-K [41], MLCK [46], and p38MAPK [47] has been
verified. Staurosporine sensitivity has been documented for
some of them. Several of the PKs are involved in the
regulation of electrolyte transport. In human erythrocytes
the phosphorylation state of the anion exchanging band 3
protein at tyrosine residues is determined by the combined
action of the PTKs p72syk and p56/53lyn in opposite to
PTP 1B [48]. Also, CK I phosphorylated band 3 protein at
threonine residues [42], while CK II phosphorylated several
structural proteins as spectrin and others, but not band 3
protein [43]. In human erythrocytes the NHE1 isoform of
Fig. 1. Increase of Mg2 + efflux (DMg2 + efflux) by increasing concen-
trations of orthovanadate in non-Mg2 +-loaded rat erythrocytes suspended in
NaCl medium. DMg2 + efflux was calculated as the difference of Mg2 +
efflux at the particular orthovanadate concentration minus Mg2 + efflux of
the control without vanadate. MeansF S.E., n= 3–5.
H. Ebel et al. / Biochimica et Biophysica Acta 1664 (2004) 150–160 153the Na+/H+ antiporter is activated by PI 3-K, which phos-
phorylates PKC~ [41]. A role of MLCK or a volume-
sensitive kinase in the regulation of Na+,K+,Cl co-transport
has been discussed [33,46]. MAPK is involved in the
regulation of NHE1 [47].
To differentiate which of these PKs might control Na+/
Mg2+ antiport, various inhibitors were tested in non-PMA-
treated erythrocytes. These were IC261 (1–100 Amol l 1)
for CK I, Ly 29402 (1–50 Amol l 1) and emodin (10–50
Amol l 1) for CK II, tyrphostin B46 (1–10 Amol l 1),
herbimycin A (0.1–10 Amol l 1), PP2 (10 nmol l 1–10
Amol l 1), lavendustin A (25 nmol l 1–10 Amol l 1) for
PTKsrc, PTKp72 syk and PTKp56/53 lyn, KN-62 (0.1–10 Amol
l 1) for CAM II-K, Ly 294102 (1–50 Amol l 1) for PI 3-K,
ML-7 (100–1000 nmol l 1) for MLCK, SB 203580 (20–
1000 nmol l 1), U0126 (20–1000 nmol l 1), PD 98059
(100–1000 nmol l 1) for the MAPK cascade. These inhib-
itors had no effect on Mg2+ efflux in non-PMA-treated
erythrocytes (data not shown). Thus, in non-PMA-stimulat-
ed erythrocytes, the staurosporine-sensitive PK activity that
affects Mg2+ efflux could not be identified.
To investigate the role of PPs in Mg2+ efflux of untreated
erythrocytes, we tested whether the inhibition of protein
phosphatases (PPs) present in erythrocytes such as the
isoenzyme PP1a [49], PP 2A [50], and PTP 1B [48] would
increase Mg2+ efflux. PTP 1B is associated with band 3
protein and can be activated by increasing [Mg2+]i [48]. All
these PPs are involved in the regulation of K+,Cl symport
[48–50]. As shown in Table 1 (see above), okadaic acid
acting as an inhibitor of erythrocyte PP 2A only slightly
increased Mg2+ efflux in NaCl medium by 3% and by 9% in
NaSCN medium. Calyculin A, an inhibitor of both PP1 and
PP 2A, showed a more pronounced inhibition of Mg2+
efflux, which was 9% in NaCl medium and 18% in NaSCN
medium. This may be taken to indicate that in non-PMA-
treated rat erythrocytes the serine/threonine phosphatase
PP1 participates in the regulation of Na+/Mg2+ antiport,
while the role of PP 2A is less clear. In human erythrocytes,
calyculin A was also a stronger inhibitor of K+,Cl symport
than okadaic acid [50]. The smaller effect of okadaic acid
compared to calyculin A may be caused by the experimental
temperature used. At 25 jC, calyculin A was a more potent
inhibitor because it permeates more rapidly than okadaic
acid [51].
The contribution of PTP 1B to Mg2+ efflux in non-PMA-
treated rat erythrocytes was investigated by using vanadate.
It has been reported that in human erythrocytes vanadate
inhibited PTP 1B followed by a strong increase in band 3
phosphorylation, [44,48,52]. As shown in Fig. 1, in NaCl
medium orthovanadate drastically increased Mg2+ efflux
five times more than PMA, as depicted in Fig. 3 (see
below). The Km of orthovanadate amounted to 55 Amol
l 1 (not shown) and was in the concentration range that
inhibited PTP [48,52]. Unfortunately, orthovanadate is a
very unspecific effector. It has digitalis-like effects on heart
muscle and induces insulin-like effects [53,54]. Further-more, vanadate inhibits various enzymes such as PTP, PP
1, PP 2A, alkaline and acid phosphatases [55–57], glyco-
lytic enzymes, e.g. GAPDH [58], and activates adenylate
cyclase [54]. In erythrocytes, vanadate is rapidly taken up
and inhibits glycolysis resulting in a reduction of the
concentrations of ATP and 2,3 BPG, which are the major
Mg2+ chelators in erythrocytes. Due to the reduction of ATP
and 2,3 BPG, bound Mg2+ will thus be liberated, which
increases [Mg2+]i. The increase in [Mg
2+]i in vanadate-
treated erythrocytes was shown directly by 31P-NMR [59].
Since increased [Mg2+]i activates Na
+/Mg2+ antiport (Ref
[1], and see below), the stimulation of Mg2+ efflux by
vanadate may be caused to a minor extent by the inhibition
of PPs, but mainly by the increase of [Mg2+]i.
3.2. Stimulation of Mg2+ efflux by PMA in non-Mg2+-
loaded erythrocytes
Treatment of erythrocytes with 1 Amol l 1 PMA stimu-
lated Mg2+ efflux. Fig. 2 shows the time course of PMA
stimulation of Mg2+ efflux. It can be seen that the PMA effect
was stable throughout the experimental period of 2 h. Fig. 3A
shows the increase of Mg2+ efflux in NaCl medium and
NaSCN medium (DMg2+ efflux) at different PMA concen-
trations. Plotting the values of Fig. 3A according to Line-
weaver–Burk yielded Km values for PMA of 51 and 53 nmol
l 1, and Vmax values of 83.3 and 43.7 Amol l cells 1 2 h 1 in
NaCl medium and NaSCN medium, respectively (Fig. 3B).
The identical Km values indicate that PMA is bound to the
membrane with the same affinity in NaCl and NaSCN
medium. PMA increased Mg2+ efflux in NaCl medium by
42%, and in NaSCN by 47% (mean values from Figs. 3A, 7
and 8). The relative stimulation of Mg2+ efflux by PMAwas
almost the same in both media. However, the absolute value
of stimulation in NaCl medium was twice that in NaSCN
medium. This may be due to the different lyotropic properties
of Cl and SCN (see Section 3.6).
Fig. 3. (A) Increase of Mg2 + efflux (DMg2 + efflux) by increasing
concentrations of PMA in non-Mg2 +-loaded rat erythrocytes suspended in
NaCl medium or NaSCN medium. Mg2 + efflux in untreated controls
amounted to 217.6F 4.5 Amol l cells 1 2 h 1 in NaCl medium and
90.3F 3.4 Amol l cells 1 2 h 1 in NaSCN medium. MeansF S.E., n= 4–
9. (B) Lineweaver–Burk plot of PMA-dependent increase of Mg2 + efflux
(DMg2 + efflux) in non-Mg2 +-loaded rat erythrocytes in NaCl medium or
NaSCN medium. Data were taken from (A). The Km value for PMAwas 51
nmol l 1 in NaCl and 53 nmol l 1 in NaSCN medium. MeansF S.E.,
n= 4–9.
Fig. 2. Time dependence of Mg2 + efflux of non-Mg2 +-loaded rat
erythrocytes suspended in NaCl medium in controls or cells treated with
1 Amol l 1 PMA. MeansF S.E., n= 3–4.
Fig. 4. Inhibition of PMA-stimulated Mg2 + efflux (DMg2 + efflux) of non-
Mg2 +-loaded rat erythrocytes in NaCl and NaSCN medium by staur-
osporine. DMg2 + efflux was calculated as the difference of Mg2 + efflux at
the particular concentration of staurosporine plus PMA minus Mg2 + efflux
of the controls without PMA and without staurosporine. MeansF S.E.,
n= 5–9.
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stimulation of Mg2+ efflux by staurosporine in NaCl and
NaSCN medium (Fig. 4). Staurosporine decreased the Mg2+
efflux below that of non-PMA-treated erythrocytes. This
agrees with the effect of staurosporine in Table 1. The IC50
values of staurosporine in NaCl medium and NaSCN
medium amounted to 196 and 199 nmol l 1, respectively
(not shown). The PKC inhibitor Ro-31-8425 dose-depen-
dently inhibited that part of the Mg2+ efflux that was
induced by PMA (DMg2+ efflux) (Fig. 5). The IC50 value
amounted to 46.5 nmol l 1 in NaCl and 50 nmol l 1 in
NaSCN medium (not shown). Furthermore, with increasing
concentrations of the specific PKC inhibitor BIM I, PMA
stimulation was inhibited, but not completely abolishedFig. 5. Inhibition of PMA-stimulated Mg2 + efflux (DMg2 + efflux) of non-
Mg2 +-loaded rat erythrocytes suspended in NaCl or NaSCN medium by
Ro-31-8425. DMg2 + efflux was calculated as the difference of Mg2 + efflux
at the particular concentration of Ro-31-8425 plus PMA minus Mg2 + efflux
of the controls without PMA and without Ro-31-8425. MeansF S.E.,
n= 4–6.
Table 2
Effect of okadaic acid and calyculin A on Mg2+ efflux of PMA-stimulated
rat erythrocytes suspended in NaCl medium or NaSCN medium
Group NaCl medium
(Amol l cells1
2 h1)
P NaSCN medium
(Amol l cells1
2 h1)
P
Control 251.3F15.2 105.0F24.1
PMA, 1 Amol l1 347.2F25.4 0.0114a 158.0F30.3 0.0058a
PMA, 1 Amol l1+
okadaic acid,
0.5 Amol l1
358.9F26.2 0.0304b 178.0F35.3 0.0175b
PMA, 1 Amol l1+
calyculin A,
0.5 Amol l1
321.9F38.9 0.0049b 169.1F14.6 n.s.b
MeansFS.E. of six paired experiments.
a Compared to control.
b Compared to PMA.
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1 Amol l 1 PMA by 35% and staurosporine was a more
effective inhibitor of Na+/H+ antiport than the more specific
PKC inhibitor Ro-31-8220 [60]. Small differences between
BIM I, Ro-31-8425 and Ro-31-8220 may be due to small
differences in the structure and specificity of these bisindo-
lylmaleimide inhibitors.
Besides representing a membrane receptor for PKC,
PMA has additional effects. PMA can serve as a non-kinase
phorbol ester/DAG receptor for a1, a2, h1, h2 chimaerine
and Ras-GRP [61]. These are proteins with a cysteine-rich
phorbol ester/DAG binding domain. They do not possess
PK activity but have a C-terminal GTPase activating do-
main, which accelerates GTP hydrolysis through small GTP
binding proteins. In the activation of MAPK, phorbol esters
mediate the binding of RAS-GAP to the plasma membrane
[61]. Therefore, it was of interest to test the effect of MAPK
and PTK inhibitors on PMA stimulation. A further reason is
that the human erythrocyte MAPK is involved in insulin
activation of the NHE1 isoform of the Na+/H+ antiporter
[47]. The MAPK cascade inhibitors SB 203580 (20–1000
nmol l 1), U0126 (20–1000 nmol l 1), PD 89059 (100–
1000 nmol l 1) did not inhibit the stimulation of Mg2+
efflux by PMA. Also the PTK inhibitors tyrphostin B46 (1–
10 Amol l 1), herbimycin A (0.1–10 Amol l 1), PP2 (10
nmol l 1–10 Amol l 1), lavendustin A (25 nmol l 1–10
Amol l 1) for PTKsrc, PTKp72 syk and PTKp56/53 lyn had no
effect (data not shown). It can thus be excluded that the
MAPK cascade and PTK play a role in PMA-stimulated
Mg2+ efflux via Na+/Mg2+ antiport.
Since staurosporine is a broad-spectrum inhibitor of
several PKs, we tested the effect of other PK inhibitors on
the stimulation of Mg2+ efflux by PMA. These were: IC261
(1–100 Amol l 1) for CK I, Ly 29402 (1–50 Amol l 1) and
emodin (10–50 Amol l 1) for CK II, KN-62 (0.1–10 AmolFig. 6. Inhibition of PMA-stimulated Mg2 + efflux (DMg2 + efflux) of non-
Mg2 +-loaded rat erythrocytes suspended in NaCl medium or NaSCN
medium by BIM I. DMg2 + efflux was calculated as the difference of Mg2 +
efflux at the particular concentration of BIM I plus PMA minus Mg2 +
efflux of the controls without PMA and without BIM I. MeansF S.E.,
n= 4–9.l 1) for CAM II-K, Ly 294102 (1–50 Amol l 1) for PI 3-K,
and ML-7 (100–1000 nmol l 1) for MLCK. These inhib-
itors did not inhibit PMA-stimulated Mg2+ efflux (data not
shown). Consequently, a role of all these PKs in regulating
Na+/Mg2+ antiport is excluded.
From the cumulative findings, it may be allowed to
conclude that in non-Mg2+-loaded rat erythrocytes, PMA
can directly stimulate Mg2+ efflux via PKCa and not via
other PKs. It is emerging so far, that in rat erythrocytes the
regulation of Mg2+ efflux via Na+/Mg2+ antiport is different
from that in hepatocytes [21,22], MDCT cells [23–26] and
other organs where Mg2+ transport is mainly regulated by
PKA.
The regulation of Mg2+ efflux via Na+/Mg2+ by PKCa
differs also from that of Na+/H+ antiport. In erythrocytes, as
in other non-epithelial tissues, only the NHE1 isoform of the
Na+/H+ exchanger (NHE) is expressed [62,63]. In erythro-
cytes [47], fibroblasts and myocardium, NHE1 has been
shown to be activated by the MAPK cascade [64–66].
Since the phosphorylation of the Na+/Mg2+ antiporter
should be controlled by the interplay of both PKCa and PPs,
we tested whether the inhibition of PPs could enhance the
PMA effect. As shown in Table 2, when PKC was already
maximally stimulated by PMA, okadaic acid caused a
further small increase of Mg2+ efflux by only 3% in NaCl
medium and by 13% in NaSCN medium. Calyculin A
caused no further increase of Mg2+ efflux in both media.
Therefore, following maximum stimulation of Mg2+ efflux
by PMA, the additional effect of PPs is small.
3.3. Stimulation of Na+-independent Mg2+ efflux by PMA in
non-Mg2+-loaded erythrocytes
The effect of PMA on Mg2+ efflux was also investigated
in KCl medium and KSCN medium, wherein Na+/Mg2+
antiport is not active. As in Na+-containing media, 1 Amol
l 1 PMA also stimulated Mg2+ efflux in K+-containing
media (Fig. 7). This was by 76% in KCl medium and by
62% in KSCN medium. In both K+-containing media, Mg2+
Fig. 7. Mg2 + efflux of non-Mg2 +-loaded rat erythrocytes suspended in
NaCl, NaSCN, KCl and KSCN medium without and with the addition of 1
Amol l 1 PMA. MeansF S.E., n= 4. *P < 0.05 for PMA vs. control.
Fig. 8. Mg2 + efflux of non-Mg2 +-loaded control and ATP-depleted rat
erythrocytes suspended in NaCl, NaSCN, KCl or KSCN medium without
and in the presence of 1 Amol l 1 PMA. DPMA is the difference of Mg2 +
efflux in the presence and the absence of PMA. MeansF S.E., n= 4.
*P< 0.05 for ATP depleted vs. control.
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unspecific choline exchanger [67]. We therefore suggest that
in addition to Na+/Mg2+ antiport, the choline exchanger can
also be regulated by the interplay of PKs and PPs.
3.4. Effect of ATP
In our first experiments on Mg2+ efflux, we found that
Mg2+ efflux via Na+/Mg2+ antiport from Mg2+-loaded
erythrocytes requires ATP [9,10]. Other transport systems
too, such as Na+/H+ antiport, Na+/Ca2+ antiport,
Na+,K+,Cl symport, and K+,Cl symport, were stimulated
by cytosolic ATP [14–17,68]. Although these transporters
are not primarily active transporters and do not consume
ATP, they are inhibited in cells whose ATP content has
been reduced.
3.4.1. Mg2+ efflux from ATP-depleted, non-Mg2+-loaded
erythrocytes
As shown in Fig. 8, following ATP depletion, Mg2+
efflux in NaCl medium was reduced by about 25%. This
indicates that Na+/Mg2+ antiport in non-Mg2+-loaded eryth-
rocytes is also stimulated by ATP. Moreover, ATP depletion
caused a 55% lower stimulation of Na+/Mg2+ antiport by
PMA and thus by PKC. Erythrocytes express extremely low
passive cation permeability [69]. Hereby, an increase of
[Na+]i within the experimental time, which would decrease
the inwardly directed Na+ gradient as a driving force for
Na+/Mg2+ antiport, can be neglected.
Remarkably, in NaSCN medium, ATP depletion
increases Mg2+ efflux, whereas in NaCl medium, Mg2+
efflux was reduced by ATP depletion (Fig. 8). This effect
may be explained by an enhanced efflux of Mg2+ together
with the highly permeating SCN for charge compensation.
Due to the reduced ATP concentration in the PKC reaction,
there was only a small effect of PMA on Mg2+ efflux in
ATP-depleted erythrocytes (Fig. 8). An increased efflux of
Mg2+ together with SCN may mask a small remaining
effect of PMA.3.5. Stimulation of Mg2+ efflux by intracellular Mg2+
We previously reported that in rat erythrocytes Mg2+
loading drastically enhanced Mg2+ efflux according to a
sigmoidal kinetic, having a Hill coefficient of n = 2.4 [2,10].
This result led to the conclusion that three Mg2+ are
simultaneously needed for Na+/Mg2+ antiport. One Mg2+
may be exchanged for two Na+ at the transport site, while
the other two intracellular Mg2+ may be bound to a modifier
site of the Na+/Mg2+ antiporter, resulting in an allosteric
activation of the antiporter [2,10].
This study again revealed a drastic increase of Mg2+
efflux by Mg2+ loading (Table 3). As already found, ATP
depletion reduced Mg2+ efflux in Mg2+-loaded rat erythro-
cytes [10]. With ATP-depleted and differently Mg2+-loaded
rat erythrocytes, we found the same Hill coefficient (n = 2.4)
as in non-ATP-depleted, Mg2+-loaded rat erythrocytes. The
log K value of the Hill plot was higher in ATP-depleted cells
(Dlog K = 0.6, not shown). This corresponds to results
obtained with reversed Na+/Mg2+ antiport of ATP-depleted
rat erythrocytes [13]. The affinity of the Mg2+ binding sites
on the Na+/Mg2+ antiporter to Mg2+ is thus dependent on
intracellular ATP. A suitable model has already been pub-
lished [2]. Recently, the same mechanism of ATP depletion
was found for the Na+/H+ antiporter. ATP depletion de-
creased the H+ affinity of the internal modifier site [70].
To determine whether PKs/PPs are additionally involved
in the activation of Na+/Mg2+ antiport by intracellular Mg2+,
we investigated the effect of PMA and staurosporine on
Mg2+ efflux from Mg2+-loaded erythrocytes. Fig. 9 shows
the time course of Mg2+ efflux in NaCl and NaSCN medium
without and with PMA in erythrocytes loaded in the
presence of 12 mmol l 1 Mg2+. PMA had no significant
effect on Mg2+ efflux in both media. As can be seen in Fig.
9, in NaSCN medium a constant lower Mg2+ efflux was
obtained as compared with NaCl medium. The failing effect
of PMA to significantly stimulate Mg2+ efflux was not due
Table 3
Na+-dependent and Na+-independent Mg2 + efflux from non-Mg2 +-loaded and Mg2 +-loaded rat erythrocytes (RBC)
Group NaCl NaSCN NaCl/NaSCN KCl KSCN KCl/KSCN
Non Mg2 +-loaded RBC (Amol l cells 1 30 min  1) 44.6F 2.9 19.8F 2.1 2.3 32.2F 0.4 20.3F 1.3 1.6
Mg2 +-loaded RBC (Amol l cells 1 30 min  1) 5979F 365 5063F 311 1.2 299F 8.4 384F 8.8 0.8
Mg2 +-loaded RBC/Non Mg2 +-loaded RBC 134 256 9.3 18.9
The RBC were suspended in NaCl, NaSCN, KCl, and KSCN medium. Mg2 + loading of RBC was done in the presence of 12 mmol l 1 MgCl2. MeansF S.E.
of four experiments.
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non-Mg2+-loaded erythrocytes, treatment with A 23187 or
with the KCl albumin-containing washing solution did not
offset the PMA stimulation of Mg2+ efflux (data not shown).
The absence of a stimulatory effect of PMA on Mg2+
efflux in Mg2+-loaded erythrocytes may have two reasons:
First, since the high [Mg2+]i may compete with [Ca
2+]i, it
may thereby prevent the activation of the Ca2+-dependent
PKCa. Second, Na
+/Mg2+ antiport may be already fully
activated by Mg2+ loading, whereby a possible additive
effect of PMA is masked.
In order to test whether Mg2+ loading itself activates
PKs, the effect of several PK inhibitors was tested in Mg2+-
loaded erythrocytes. Staurosporine (1 Amol l 1), BIM I
(0.5–1.0 Amol l 1) and Ro-31-8425 (0.1–1.0 Amol l 1)
had no significant effect on Mg2+ efflux (data not shown).
Therefore, in the drastic activation of Mg2+ efflux by Mg2+
loading, an activation of PKCa and other PKs is not
involved. Also, inhibition of PPs by 1 Amol l 1 calyculin
A had no effect on Mg2+ efflux of Mg2+-loaded rat eryth-
rocytes (not shown).
Based on these results, we conclude that the activation
of Mg2+ efflux by Mg2+ loading is caused by a direct
effect of intracellular Mg2+ together with ATP either on
the Na+/Mg2+ antiporter or an associated regulatory
protein.Fig. 9. Time dependence of Mg2 + efflux of rat erythrocytes loaded with 12
mmol l 1 Mg2 + in the Mg2 + loading medium. Mg2 + efflux was measured
in NaCl medium and NaSCN medium without or in the presence of 1 Amol
l 1 PMA. MeansF S.E., n= 3–5.3.5.1. Na+-independent Mg2+ efflux in Mg2+-loaded rat
erythrocytes
Mg2+ loading increased Na+-independent Mg2+ efflux
(Mg2+ efflux in KCl and KSCN medium) in parallel to the
increased Mg2+ gradient (about 9 to 19 times, respectively).
Na+-dependent Mg2+ efflux through Na+/Mg2+ antiport was
increased by a factor of 134 and 256 in NaCl and NaSCN
medium, respectively (Table 3).
3.6. Role of intracellular Cl in the regulation of Mg2+
efflux
We previously showed that in non-Mg2+-loaded erythro-
cytes suspended in NaSCN medium with zero [Cl]i, there
was a residual Mg2+ efflux amounting to 30–40% of Mg2+
efflux in NaCl medium [32]. With increasing [Cl]i, pro-
duced by the substitution of NaSCN by NaCl, Mg2+ efflux
was stimulated according to a sigmoidal kinetic having a Hill
coefficient for [Cl]i of 1.6–1.8 [32]. The Mg
2+ efflux
remaining at zero [Cl]i may be caused by [Cl
]i– indepen-
dent Na+/Mg2+ antiport or by Mg2+ efflux through another
pathway, e.g. through the unspecific choline antiporter,
which also accepts other cations instead of choline [67].
Calculating the difference of Mg2+ efflux in NaCl medium
minus KCl medium from Fig. 7 yielded 75.4 Amol l cells 1 2
h 1. The difference of Mg2+ efflux in NaSCN medium
minus KSCN medium amounted to  2.4 Amol l cells 1 2
h 1. This result shows that Na+/Mg2+ antiport in non-Mg2+-
loaded erythrocytes essentially depends on intracellular Cl.
Mg2+ efflux in NaSCN, KCl, and KSCN medium can be
explained by Na+/Mg2+ exchange and K+/Mg2+ exchange
through the unspecific choline exchanger [67]. Moreover,
Fig. 7 shows that PMA stimulated Mg2+ efflux in the absence
of intracellular Cl in NaSCN medium and KSCN medium.
From these findings, we conclude that the stimulation of
Na+-dependent and Na+-independent Mg2+ efflux by PMA
does not depend on [Cl]i.
The role of [Cl]i in the activation of Mg
2+ efflux by
PMA at elevated [Mg2+]i was also investigated in Mg
2+-
loaded erythrocytes suspended in NaSCN medium. Fig. 9
shows that PMA had no significant effect on Mg2+ efflux in
NaSCN medium, as was found for NaCl medium. As with
non-Mg2+-loaded erythrocytes, Mg2+ efflux in NaSCN
medium was lower than in NaCl medium. However, in
Mg2+-loaded erythrocytes the difference and ratio between
Mg2+ efflux in NaCl and NaSCN medium was smaller than
that in non-Mg2+-loaded erythrocytes (Fig. 9, Table 3). It
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erythrocytes may be less dependent on intracellular Cl.
Similarly, Mg2+ efflux in Mg2+-loaded erythrocytes in K+-
containing medium, which may operate through the choline
exchanger by K+/Mg2+ exchange, was also less dependent
on intracellular Cl (Table 3). These effects may be
explained by the different lyotropic properties of SCN
and Cl according to the Hofmeister series, although the
exact mechanism of interaction of Mg2+ and both anions
with the antiporters is not known.
In conclusion, the drastic activation of Na+/Mg2+ antiport
by intracellular Mg2+ overwhelms the other activating
regulatory mechanisms of activation by [Cl]i and by
PKCa/protein phosphatases because the Na
+/Mg2+ antiport
in Mg2+-loaded erythrocytes is operating at its maximal
capacity.
3.7. Exclusion of TRPM7 as Na+/Mg2+ antiporter
As shown by kinetic analysis, Na+/Mg2+ antiport must be
mediated by a single protein and not by the combination of a
Na+-transporting and a Mg2+-transporting protein [9,71]. Its
structure is yet to be characterized. It may be asked whether
the newly cloned and functionally characterized TRPM7
performs Na+/Mg2+ antiport. The main differences between
TRPM7 and the Na+/Mg2+ antiporter are as follows.
TRPM7 is a bifunctional protein with intrinsic cation
channel and PK domains. It acts as a nonspecific metal ion
pathway, conducting divalent cations into the cell. At
positive potentials and submillimolar Mg2+ concentrations,
it also mediates influx or efflux of monovalent cations [72–
75]. The Na+/Mg2+ antiporter is an electroneutral antiporter
that under physiological conditions exchanges extracellular
Na+ for intracellular Mg2+.
Mg2+ influx via TRPM7 is inhibited by intracellular Mg
and MgATP [72]. As shown previously [9,13] and in this
study, Na+/Mg2+ antiport is drastically activated by intra-
cellular Mg and ATP.
The a-kinase associated with TRPM7 is not sensitive
to staurosporine [76], but is inhibited by H89 [77]. As
shown in this study, the opposite is true for Na+/Mg2+
antiport. This excludes that the unidentified PK affecting
Na+/Mg2+ antiport is identical to the a-kinase of TRPM7.
From the cumulative evidence, we conclude that TRPM7
is not identical to Na+/Mg2+ antiporter.
3.8. Functional consequences
Mg2+ efflux is low in untreated erythrocytes. This low
Mg2+ efflux is regulated by [Cl]i, ATP, and by the interplay
of unidentified PK activity with PPs. A rather constant
[Mg2+]i can thereby be maintained. The most drastic regu-
lation of Mg2+ efflux is induced by intracellular Mg2+.
When [Mg2+]i is increased, e.g. by Mg
2+ loading or in
hypermagnesemia and, in case of ATP depletion as in
hypoxia and acidosis, a drastic increase of Mg2+ effluxthrough Na+/Mg2+ antiport is induced. For details of the
mechanism, see Ref. [2]. Thus, the physiological concen-
tration of [Mg2+]i will be rapidly reached. An optimal
function of the Mg2+-dependent enzymes is thereby estab-
lished. Furthermore, in nucleated cells, miscoding is pre-
vented and the action of initiation and dissociation factors in
protein biosynthesis is facilitated [78].Acknowledgements
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